Weigao (1066) Announces Extraordinary General Meeting Proxy Form

Bulletin Express12-02

Shandong Weigao Group Medical Polymer Company Limited (1066) released a proxy form for its extraordinary general meeting, set for 17 December 2025 at 8:30 a.m. at the company’s office in Weihai, Shandong, PRC.

The agenda includes four ordinary resolutions: approving the Purchase Framework Agreement and the transactions under it; approving the Logistic Support Services Framework Agreement and the transactions under it; reappointing Mr. Li Qiang as an independent non-executive director; and approving the change of company type. The proxy form must be completed and submitted according to the instructions specified in the announcement, and attendance at the meeting remains possible for shareholders who submit proxies by the required deadline.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment